127 related articles for article (PubMed ID: 26049033)
21. Expression of SIRT1 in gastric cardiac cancer and its clinicopathologic significance.
Feng AN; Zhang LH; Fan XS; Huang Q; Ye Q; Wu HY; Yang J
Int J Surg Pathol; 2011 Dec; 19(6):743-50. PubMed ID: 21865267
[TBL] [Abstract][Full Text] [Related]
22. Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway.
Deng S; Zhu S; Wang B; Li X; Liu Y; Qin Q; Gong Q; Niu Y; Xiang C; Chen J; Yan J; Deng S; Yin T; Yang M; Wu H; Wang C; Zhao G
Cancer Lett; 2014 Dec; 355(2):184-91. PubMed ID: 25172416
[TBL] [Abstract][Full Text] [Related]
23. KrĂĽppel-like factor 8 involved in hypoxia promotes the invasion and metastasis of gastric cancer via epithelial to mesenchymal transition.
Liu N; Wang Y; Zhou Y; Pang H; Zhou J; Qian P; Liu L; Zhang H
Oncol Rep; 2014 Dec; 32(6):2397-404. PubMed ID: 25333643
[TBL] [Abstract][Full Text] [Related]
24. Molecular Mechanism of Resistance to Chemotherapy in Gastric Cancers, the Role of Autophagy.
Spirina LV; Avgustinovich AV; Afanas'ev SG; Cheremisina OV; Volkov MY; Choynzonov EL; Gorbunov AK; Usynin EA
Curr Drug Targets; 2020; 21(7):713-721. PubMed ID: 31775598
[TBL] [Abstract][Full Text] [Related]
25. ACK1 promotes gastric cancer epithelial-mesenchymal transition and metastasis through AKT-POU2F1-ECD signalling.
Xu SH; Huang JZ; Xu ML; Yu G; Yin XF; Chen D; Yan GR
J Pathol; 2015 Jun; 236(2):175-85. PubMed ID: 25678401
[TBL] [Abstract][Full Text] [Related]
26. DSGOST regulates resistance via activation of autophagy in gastric cancer.
Kim TW; Lee SY; Kim M; Cheon C; Jang BH; Shin YC; Ko SG
Cell Death Dis; 2018 May; 9(6):649. PubMed ID: 29844404
[TBL] [Abstract][Full Text] [Related]
27. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer.
Yu J; Liang QY; Wang J; Cheng Y; Wang S; Poon TC; Go MY; Tao Q; Chang Z; Sung JJ
Oncogene; 2013 Jan; 32(3):307-17. PubMed ID: 22370639
[TBL] [Abstract][Full Text] [Related]
28. Rab3IP interacts with SSX2 and enhances the invasiveness of gastric cancer cells.
Ren H; Xu Z; Guo W; Deng Z; Yu X
Biochem Biophys Res Commun; 2018 Sep; 503(4):2563-2568. PubMed ID: 30005870
[TBL] [Abstract][Full Text] [Related]
29. Janus-faced role of SIRT1 in tumorigenesis.
Song NY; Surh YJ
Ann N Y Acad Sci; 2012 Oct; 1271(1):10-9. PubMed ID: 23050959
[TBL] [Abstract][Full Text] [Related]
30. Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.
Santini D; Vincenzi B; Fratto ME; Perrone G; Lai R; Catalano V; Cass C; Ruffini PA; Spoto C; Muretto P; Rizzo S; Muda AO; Mackey JR; Russo A; Tonini G; Graziano F
J Cell Physiol; 2010 May; 223(2):384-8. PubMed ID: 20082300
[TBL] [Abstract][Full Text] [Related]
31. Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells.
Shi M; Lou B; Ji J; Shi H; Zhou C; Yu Y; Liu B; Zhu Z; Zhang J
Cancer Chemother Pharmacol; 2013 Jul; 72(1):35-44. PubMed ID: 23712327
[TBL] [Abstract][Full Text] [Related]
32. Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance.
Kapranos N; Kominea A; Konstantinopoulos PA; Savva S; Artelaris S; Vandoros G; Sotiropoulou-Bonikou G; Papavassiliou AG
J Cancer Res Clin Oncol; 2002 Aug; 128(8):426-32. PubMed ID: 12200599
[TBL] [Abstract][Full Text] [Related]
33. SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis.
Chen HC; Jeng YM; Yuan RH; Hsu HC; Chen YL
Ann Surg Oncol; 2012 Jun; 19(6):2011-9. PubMed ID: 22146883
[TBL] [Abstract][Full Text] [Related]
34. Exosomes participate in the carcinogenesis and the malignant behavior of gastric cancer.
Yan Y; Fu G; Ye Y; Ming L
Scand J Gastroenterol; 2017 May; 52(5):499-504. PubMed ID: 28128667
[TBL] [Abstract][Full Text] [Related]
35. Prognostic and clinical value of Sirt1 expression in gastric cancer: A systematic meta-analysis.
Jiang B; Chen JH; Yuan WZ; Ji JT; Liu ZY; Wu L; Tang Q; Shu XG
J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):278-284. PubMed ID: 27072976
[TBL] [Abstract][Full Text] [Related]
36. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
37. Haploinsufficiency of SIRT1 Enhances Glutamine Metabolism and Promotes Cancer Development.
Ren NSX; Ji M; Tokar EJ; Busch EL; Xu X; Lewis D; Li X; Jin A; Zhang Y; Wu WKK; Huang W; Li L; Fargo DC; Keku TO; Sandler RS; Li X
Curr Biol; 2017 Feb; 27(4):483-494. PubMed ID: 28162896
[TBL] [Abstract][Full Text] [Related]
38. Targeting SIRT1-regulated autophagic cell death as a novel therapeutic avenue for cancer prevention.
Patra S; Praharaj PP; Singh A; Bhutia SK
Drug Discov Today; 2023 Sep; 28(9):103692. PubMed ID: 37379905
[TBL] [Abstract][Full Text] [Related]
39. Autophagy regulation and its role in gastric cancer and colorectal cancer.
Zhou H; Yuan M; Yu Q; Zhou X; Min W; Gao D
Cancer Biomark; 2016 Jun; 17(1):1-10. PubMed ID: 27314289
[TBL] [Abstract][Full Text] [Related]
40. SIRT1 mediated gastric cancer progression under glucose deprivation through the FoxO1-Rab7-autophagy axis.
Zhu M; Wei C; Wang H; Han S; Cai L; Li X; Liao X; Che X; Li X; Fan L; Qiu G
Front Oncol; 2023; 13():1175151. PubMed ID: 37293593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]